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T HOUSANDS of volatile organic compounds (VOCs) are expelled with each breath. The composition of these 
VOCs can change with the state of health.1–10 Breath analysis 
has consequently become a promising field of research. One 
suitable tool for breath analysis is multicapillary column 
ion-mobility spectrometry (MCC-IMS). The MCC-IMS 
is a noninvasive and rapid method for detection of VOCs 
in exhaled breath. The principles of MCC-IMS have been 
described previously.11,12 MCC-IMS is already used exten-
sively for detection of drugs, chemicals, and explosives.13,14 
But this technique has already been used for evaluation of 
pulmonary diseases, that is, chronic obstructive pulmonary 
disease,1–3 acute respiratory distress syndrome,4 lung cancer, 
and airway infections.1,6,15 Furthermore, it also appears pos-
sible to detect volatile metabolites arising from various bac-
terial species.7–10
Based on these results using MCC-IMS for diagnosis of 
pulmonary diseases and inflammation, the question rises if 
systemic inflammation and sepsis are also appropriated targets 
for this novel noninvasive device. To our knowledge, only one 
study from Guamán et al.15 used gas chromatography–mass 
spectrometry to evaluate the systemic inflammatory response 
to intraperitoneal lipopolysaccharide in rats.
But whether MCC-IMS can be used on exhaled breath 
as a measure of sepsis and systemic inflammation remains 
unknown. We therefore compared patterns of exhaled 
organic compounds in septic, endotoxemic shock (ES), 
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ABSTRACT
Background: Multicapillary column ion-mobility spectrometry (MCC-IMS) may identify volatile components in exhaled 
gas. The authors therefore used MCC-IMS to evaluate exhaled gas in a rat model of sepsis, inflammation, and hemorrhagic 
shock.
Methods: Male Sprague–Dawley rats were anesthetized and ventilated via tracheostomy for 10 h or until death. Sepsis was 
induced by cecal ligation and incision in 10 rats; a sham operation was performed in 10 others. In 10 other rats, endotoxemia 
was induced by intravenous administration of 10 mg/kg lipopolysaccharide. In a final 10 rats, hemorrhagic shock was induced 
to a mean arterial pressure of 35 ± 5 mmHg. Exhaled gas was analyzed with MCC-IMS, and volatile compounds were identi-
fied using the BS-MCC/IMS-analytes database (Version 1209; B&S Analytik, Dortmund, Germany).
Results: All sham animals survived the observation period, whereas mean survival time was 7.9 h in the septic animals, 9.1 h 
in endotoxemic animals, and 2.5 h in hemorrhagic shock. Volatile compounds showed statistically significant differences 
in septic and endotoxemic rats compared with sham rats for 3-pentanone and acetone. Endotoxic rats differed significantly 
from sham for 1-propanol, butanal, acetophenone, 1,2-butandiol, and 2-hexanone. Statistically significant differences were 
observed between septic and endotoxemic rats for butanal, 3-pentanone, and 2-hexanone. 2-Hexanone differed from all other 
groups in the rats with shock.
Conclusions: Breath analysis of expired organic compounds differed significantly in septic, inflammation, and sham rats. 
MCC-IMS of exhaled breath deserves additional study as a noninvasive approach for distinguishing sepsis from inflammation.
(Anesthesiology 2015; 122:117-26)
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and sham-control rats during an observation period of 
10 h. A further group of pressure-controlled hypotension 
was used to distinguish between infection, inflammation, 
and noninfectious shock in exhaled metabolites. Non-
infectious shock was included to distinguish changes in 
VOCs resulting from infection/inflammation versus hypo-
tension alone.
Material and Methods
Animals
All experiments were conducted with approval from our 
Animal Care and Use Committee (Landesamt für Sozia-
les, Gesundheit und Verbraucherschutz; Saarbrücken; Ger-
many) and in accordance with the German Animal Welfare 
Act. Male Sprague–Dawley rats (200 to 300 g body weight) 
were obtained from Charles River (Sulzfeld, Germany) and 
kept in the institutional animal facility under controlled 
conditions (temperature 20° ± 2°C and 50 ± 5% humidity). 
Animals had free access to water; standard pellet food was 
withheld for 12 h before the experiment.
Chemicals
Pure lipopolysaccharide of Escherichia coli serotype O26:B6 
was obtained from Sigma-Aldrich (Munich, Germany).
Surgical Procedures
Rats were anesthetized with pentobarbital 60 mg/kg intra-
peritoneally and positioned on a warming plate; an open 
tracheotomy was performed to facilitate breathing. The right 
external jugular vein was catheterized to allow for infusion, 
and the left carotid artery was catheterized for continuous 
measurement of mean arterial pressure (MAP) and heart rate 
(Philips IntelliVue MP20 Junior, Boeblingen, Germany).
Afterward the rats were connected to the respirator 
(KTR-5 small animal ventilator; Hugo Sachs Elektronik-
Harvard Apparatus, March-Hugstetten, Germany) and 
ventilated with highly purified synthetic air (Air Liquid, 
Ludwigshafen, Germany). The MCC-IMS (type Breath 
discovery; B&S Analytik, Dortmund, Germany) was con-
nected to the same tank of synthetic air.
Tidal volume was adapted to a physiological lift of the 
thorax wall and respiratory rate set to 65 min−1 at an inspira-
tion ratio of 45% and a positive end-expiratory pressure of 1 
to 2 cm H2O. General anesthesia was maintained through-
out the study with pentobarbital intravenously as needed. 
The rats were given intravenous isotonic solution at a rate 
of 10 ml kg−1 h−1 (Sterofundin ISO; B. Braun, Melsungen, 
Germany).
Experimental Protocol
We evaluated four groups of 10 rats each, randomly assigned to 
sepsis (CLI), ES, hemorrhagic shock (HS), and sham control:
CLI: Sepsis was induced using a modified model of cecal 
ligation and incision as previously described.16,17 The 
cecum was exteriorized through a midline laparotomy, 
and the cecum and paracecal blood vessels were ligated 
below the ileocecal valve. The ligated cecum was 
incised 1.5 cm on the antimesenteric side and replaced 
in the abdomen, and the abdominal wall was closed.
Sham: Sham-operated rats were treated likewise but 
without ligation and incision.
ES: ES was induced by administration of 10 mg/kg lipo-
polysaccharide E. coli serotype O26:B6 intravenously.
HS: A modified pressure-regulated shock model was used 
as described preciously,18,19 but without resuscitation 
and retransfusion. HS was induced by rapid arterial 
blood withdrawal by way of the carotid artery with a 
MAP of 35 ± 5 mmHg.
Induction of sepsis or sham operation was carried out by 
the same investigator and subsequently blinded during the 
observation period. ES and HS groups were also carried out 
by the same investigator, but blinding was not realizable. 
When measurements were finished, all surviving rats were 
killed with an overdose of pentobarbital.
Arterial blood (0.2 ml) was sampled every 2.5 h for analy-
sis of pH, base excess, lactate, hemoglobin, glucose, partial 
pressures of oxygen, and carbon dioxide (Radiometer ABL 
800 Basic, Willich, Germany). After insertion of the arte-
rial catheter, and 5 h after induction of CLI, blood samples 
(0.5 ml) were taken for enzyme-linked immunosorbent assay 
(ELISA) analysis of pro- and antiinflammatory cytokines.
MCC-IMS Measurements
We used a Bioscout 2011 MCC-IMS based on a 550 MBq 
63Ni ionization source with an electrical field strength of 
300 V/cm and equipped with MCC using a general-pur-
pose, slightly polar standard capillary column phase OV-5 
(Multichrom, Novosibirsk, Russia).
Before connecting the rats to the MCC-IMS, we mea-
sured background concentrations of organic volatile 
compounds from the respirator for 1 h. Throughout the 
experiment, the rats were ventilated with synthetic air as 
described previously.20 To avoid any extraneous signals, 
polytetrafluoroethylene (Bohlender, Grünsfeld, Germany) 
was used for all external connections, and the MCC-IMS 
sampling tube was directly connected to the exhalatory 
line of the respirator. Breath humidity and cluster reactions 
between ions and water lead to significant changes of the 
IMS spectra; therefore we used a MCC coupled with an ion-
mobility spectrometer to avoid this error.
Exhaled gas (10 ml per measurement) was collected in the 
sample loop before entering the multicapillary column of the 
ion-mobility spectrometer. This arrangement allowed three 
measurements per hour. The retention time in relation to the 
preseparation of the MCC, drift time of the ions within the 
IMS, and the intensity of the analytes were delivered by the 
MCC-IMS and subsequently identified using the BS-MCC/
IMS-analytes database (Version 1209; B&S Analytik).
Downloaded From: http://anesthesiology.pubs.asahq.org/ on 09/04/2015
Anesthesiology 2015; 122:117-26 119 Fink et al.
CRITICAL CARE MEDICINE
Peaks representing various VOCs were identified using 
Visual Now 3.1 (B&S Analytik). All signals above the thresh-
old of 1 mV to 5 V (peak range: lower limit is defined as five 
times over the background noise; the upper limit depends 
on the saturation of the drift tube) were defined as a peak 
and characterized by their position with drift time, retention 
time, and concentration related to the peak intensity.
Cytokine Assay
Cytokine concentrations were measured by ELISA. Posi-
tive controls of each cytokine were measured routinely with 
each assay (ELISA Antibodies BD OptEIA; BD Biosciences 
Pharmingen, San Diego, CA).
Statistical Analysis and Signal Processing
Mathematical and statistical evaluation was carried out 
using SigmaPlot (version 12.5; Systat Software, Erkrath, 
Germany).
Based on our previous experience, we confirmed a num-
ber of 10 rats per group as sufficient to see clear differences. 
Animals were randomized in four groups using a random 
number generator (Excel 2010; Microsoft, Redmond, WA).
Survival time was analyzed using a log-rank model 
according to Kaplan–Meier, followed by an all-pairwise 
comparison using Tukey test.
Data were tested for distribution normality (Kol-
mogorov–Smirnov test) and analyzed using repeated-mea-
sures ANOVA, followed by post hoc multiple comparisons 
with Holm–Sidak method. When appropriate, repeated-
measures ANOVA on ranks were used. Based on the survival 
rate, statistical analysis for each volatile compound was per-
formed from 0 to 6 h in the sham, sepsis, and endotoxemic 
group.
Hemorrhagic shock group was merely analyzed after 2 h 
using one-way ANOVA followed by post hoc multiple com-
parisons with the Holm–Sidak method. A two-tailed P value 
of less than 0.05 was considered statistically significant.
Results
Survival Time, Blood Gas Analysis, and Cytokines
All sham rats survived the observation period, whereas oth-
ers died earlier: HS: mean, 2.5 ± 0.3 h; 95% CI, 1.9 to 3.1 h; 
CLI: mean, 7.9 ± 0.4 h; CI, 7.2 to 8.7 h; and, ES: mean, 
9.1 ± 0.4 h; and CI, 8.3 to 9.9 h. All P values less than 0.001 
versus sham (fig. 1).
All blood gas values remained stable and normal in sham-
operated rats. In contrast, blood lactate concentrations 
increased significantly over time in CLI, ES, and HS rats. 
Arterial base excess and pH were significantly lower in the 
CLI and ES groups than sham rats (table 1). Respiratory 
parameters (partial pressure of oxygen, partial pressure of 
carbon dioxide, and oxygenation index), hemoglobin, and 
blood glucose remained within normal ranges throughout 
the experiment in both groups.
Baseline concentrations of tumor necrosis factor-α, inter-
leukin-6, and interleukin-10 were similar at the beginning 
of the experiment. However, concentrations of all three 
increased significantly in the septic and endotoxemic rat 
(table 2).
Hemodynamic Parameters
Baseline MAP was similar in all groups and remained 
stable throughout in the sham-operated rats (fig. 2). 
Induction of HS resulted in a significant decline of MAP. 
Injection of lipopolysaccharide resulted in an early reduc-
tion of MAP from 1 to 2 h and further at 5 h and there-
after. MAP gradually declined in the CLI rats, becoming 
significantly lower than in the sham group after 5 h. The 
heart rate remained within normal ranges during the 
entire observation period, without significant differences 
between the groups.
Multicapillary Column Ion-mobility Spectrometry
During the experiment, about a hundred different signals 
between a threshold of 1 mV and 5 V (peak definition) were 
detected in exhaled air. Seven signals presented with signifi-
cant differences between groups during the first 6 h of the 
observation period. Those seven were considered potentially 
useful VOCs for distinguishing among treatments. Figure 3 
illustrates the typical IMS chromatogram of 3-pentanone 
and a three-dimensional plot for this setting.
Fig. 1. Survival rate. After hemorrhagic shock (HS), endotox-
emic shock (ES), and sepsis (CLI), mean survival time was sig-
nificantly decreased compared with sham control. *P < 0.001 
for sham versus HS, ES, and CLI.
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With the BS-MCC/IMS-analytes database (Version 
1209), all seven potential compounds could be identified 
according to their retention time and drift time. All these 
VOCs are shown in table 3.
As a result of the measured survival time (fig. 1), the statis-
tical analysis of each VOC was performed at 0, 2, 4, and 6 h 
in the sham, CLI, and ES (each n = 10 per group at these time 
points). Sham-operated rats presented with approximately 
stable concentrations of all VOCs throughout the observation 
period. During the experiment, seven VOCs decreased signifi-
cantly in lipopolysaccharide-treated rats, when compared with 
sham. At 2 h and thereafter 1-propanol (P < 0.04), butanal 
(P < 0.001), acetophenone (P < 0.022), 1,2-butandiol (P < 
0.001), 3-pentanone (P < 0.001), acetone (P < 0.001), and 
2-hexanone (P < 0.001), all decreased (table 3 and figs. 4–6).
In the septic rats, though, only two compounds decreased 
significantly. 3-Pentanone (P < 0.001) and acetone (P = 0.02) 
decreased at 6 h (table 3 and figs. 4 and 5).
Overall, there were significant differences between ES and 
CLI in the concentrations of three VOCs: butanal (P < 0.001 
at 2 h and thereafter), 3-pentanone (P < 0.001 at 2 h and 
thereafter), and 2-hexanone (P < 0.001 at 2 h and thereafter 
(table 3 and figs. 4 and 6).
Noninfectious shock was included to distinguish changes 
in VOCs resulting from infection or inflammation versus 
hypotension alone. Due to the high mortality in this group, 
a single statistical evaluation was performed at 2 h after 
induction of HS:
There was significant increase in 2-hexanone (P < 0.001) 
when compared with all other groups, and for butanal 
Table 1. Arterial Blood Gas Analysis
0 h 2.5 h 5 h 7.5 h 10 h
Survival rate (N = )
  Sham 10 10 10 10 10
  CLI 10 10 10 7 2
  ES 10 10 10 8 5
  HS 10 5
pH
  Sham 7.39 (7.34–7.49) 7.42 (7.38–7.45) 7.41 (7.35–7.48) 7.42 (7.36–7.54) 7.39 (7.35–7.42)
  CLI 7.37 (7.31–7.44) 7.35 (7.20–7.44) 7.26* (7.16–739) 7.23*† (7.13–7.40) 7.23 (7.23–7.26)
  ES 7.41 (7.32–7.52) 7.36 (7.28–7.46) 7.36 (7.14–7.52) 7.30 (7.11–7.46) 7.29 (7.25–7.30)
  HS 7.40 (7.30–7.50) 7.41 (7.30–7.54)
Base excess
  Sham −0.5 (−6.0 to 5.7) −3.6 (−6.1 to −1.8) −3.9 (−5.4 to −2.6) −4.0 (−7.2 to −1.5) −3.8 (−6.9 to −3.2)
  CLI −1.1 (−8.4 to 5.4) −5.6 (−12.3 to 0.2) −10.1*† (−17.9 to −2.1) −14.8*† (−25.9 to −7.1) −15.0 (−18.0 to −12.0)
  ES 2.3 (−2.4 to 6.1) −5.1 (−9.4 to 0.0) −6.0*† (−14.4 to 0.7) −11.6*† (−23.8 to −1.7) −10.9 (−13.6 to −80)
  HS 2.5 (−0.2 to 5.8) −5.7 (−12.3 to −0.6)
Lactate
  Sham 0.9 (0.5–1.6) 0.6 (0.5–0.8) 0.9 (0.6–1.4) 0.7 (0.4–1.1) 0.6 (0.4–0.9)
  CLI 0.9 (0.5–1.8) 1.1 (0.6–1.8) 2.4 (1.0–4.7) 4.1*† (1.3–7.2) 6.2 (5.2–7.2)
  ES 0.7 (0.5–1.0) 1.0 (0.5–1.4) 2.6*† (1.4–5.3) 4.9*† (3.0–9.4) 4.5 (3.9–5.4)
  HS 0.6 (0.4–1.0) 3.2 (2.2–6.0)
Partial pressure of oxygen
  Sham 82.5 (59.1–119) 75.8 (63.7–87.2) 82.1 (41.5–131) 77.8 (50.7–154) 79.1 (61.2–123)
  CLI 73.1 (59.8–121) 79.4 (48.8–99.7) 82.7 (47.8–95.2) 73.0 (68.1–87.0) 77.6 (46.2–93.4)
  ES 83.9 (51.5–127) 75.2 (58.5–105) 91.9 (60.7–166) 87.7 (85.1–127) 80.6 (68.9–126)
  HS 72.1 (35.6–100) 73.0 (50.0–123)
Partial pressure of carbon dioxide
  Sham 35.1 (24.0–40.9) 31.3 (25.3–37.9) 30.9 (22.5–37.1) 29.4 (18.2–41.6) 32.0 (26.0–40.0)
  CLI 37.6 (30.4–44.2) 32.4 (23.9–39.4) 32.9 (25.7–43.7) 24.5 (17.7–35.6) 29.7 (28.4–31.0)
  ES 36.6 (23.3–44.9) 33.2 (28.2–38.9) 34.6 (20.4–44.5) 29.0 (17.0–36.4) 24.2 (21.6–28.0)
  HS 37.7 (30.7–47.8) 28.1 (19.4–31.0)
Oxygen index
  Sham 393 (281–567) 361 (303–415) 391 (197–623) 370 (279–480) 382 (241–633)
  CLI 348 (285–576) 378 (246–661) 394 (232–475) 315 (227–405) 371 (324–414)
  ES 400 (245–480) 358 (301–537) 438 (279–500) 419 (289–790) 384 (343–504)
  HS 343 (257–585) 348 (469–619)
Data are given as means ± 95% CIs. Arterial blood gas analysis revealed normal baseline values for pH, base excess, lactate, partial pressure of oxygen, 
and carbon dioxide. Lactate values increase significantly, and pH and base excess decrease significantly over time, when compared with sham control. 
Respiratory parameters: partial pressure of oxygen and carbon dioxide as oxygenation index (partial pressure of oxygen/oxygen fraction) remained within 
normal ranges throughout the experiment. Statistical analysis was performed from 0 to 7.5 h.
* P < 0.05 vs. sham group. † P < 0.05 vs. corresponding baseline.
CLI = sepsis; ES = endotoxemic shock; HS = hemorrhagic shock.
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(P < 0.006), 3-pentanone (P < 0.001), and acetone (P < 0.001) 
when compared with endotoxemia. However, none of the 
VOCs decreased significantly compared with sham (table 3).
Table 4 gives an overview of changes in volatile com-
pounds with significant differences after 6 h.
Discussion
Currently, diagnosis of sepsis and septic shock relies on non-
specific physiological signs, and early appropriate treatment 
remains of prime importance. Common diagnostic tools, 
such as blood culture techniques, procalcitonin, ELISA, or 
polymerase chain reaction, harbor a series of drawbacks and 
limitations.21–26 MCC-IMS may prove to be an innovative 
tool to complement conventional diagnostic techniques.15 
Major advantages of the technique lie in its noninvasive 
character and near-real-time bedside analysis.8
We are aware of only a single previous study in which expired 
gas was used to detect a systemic inflammatory response.15 In 
that study, IMS and gas chromatography–mass spectrometry 
were used to evaluate the systemic inflammatory response to 
intraperitoneal lipopolysaccharide in rats. Our use of MCC-IMS 
technology for VOC assessment of sepsis appears to be novel.
We observed a total of 100 signals in exhaled air, between 
a threshold of 1 mV and 5 V, which was defined as peak 
range. Seven VOCs presented with significant difference 
between the investigated groups during the first 6 h of the 
experiment and have to be chosen as potential VOCs to dis-
tinguish between research groups.
All detected compounds could be identified; the most 
were ketones, hydrocarbons, alcohols, and ethers. Previous 
investigators, using different methodologies, found similar 
compounds in the breath of humans,27,28 rats,15 and mice29 
and also in the headspace samples of bacteria cultures.7,8,10,30 
Our focus, though, was not on peak identity, but in differ-
ences between sepsis, inflammation, and shock.
Our experimental model of fulminant four-quadrant 
peritonitis presumably better represents clinical sepsis than 
lipopolysaccharide endotoxemia, but also poses several prob-
lems. During CLI sepsis, rats presented with three clinical 
entities: infection, inflammation, and shock. To distinguish 
among them, we used two further models: one with a sys-
temic inflammatory response induced by lipopolysaccharide 
and another with a pressure-controlled HS.
In comparison with untreated animals, most volatile 
compounds detected in sepsis and inflammation animals 
declined over time, as did hemodynamic compensation. 
However, none of these compounds similarly declined dur-
ing HS; in contrast, HS was the only condition associated 
with an increase in VOCs. Also surprisingly, the “sterile” 
inflammation after injection of lipopolysaccharide seemed to 
have more altered the most VOCs than the complex model 
of polymicrobial sepsis. Thus, the observed alterations in vol-
atile compounds during sepsis are unlikely to be the result of 
hemodynamic decompensation, but seem more likely due to 
factors specific to sepsis, inflammation, or consequent pul-
monary impairments. Furthermore, all animals presented 
with a normal oxygenation index during the experiment, so 
the distinction between groups is unlikely influenced by the 
degree of lung injury.
Table 2. Cytokine Response
0 h 5 h
 (N = 10 per Group) (N = 10 per Group)
Tumor necrosis factor-α, pg/ml
  Sham 0.0 (0.0–0.0) 0.0 (0.0–0.0)
  CLI 0.1 (0.0–0.3) 17.9 (0.0–37.1)*
  ES 0.2 (0.0–2.0) 27.10 (2.3–62.1)*
Interleukin-10, pg/ml
  Sham 0.0 (0.0–0.0) 0.0 (0.0–0.0)
  CLI 5.1 (0.0–16.5) 312 (84.4–784)*
  ES 2.3 (0.0–7.5) 184 (10.0–365)*
Interleukin-6, pg/ml
  Sham 374 (279–677) 377 (267–505)
  CLI 375 (346–404) 11,223 (1,223–31,790)*
  ES 315 (160–412) 17,663 (1,246–41,598)*
CLI and ES significantly increased tumor necrosis factor-α, interleukin-10, 
and interleukin-6 compared with sham-operated rats. Data are given as 
means ± 95% CI (n = 10 per group at 0 and 5 h).
* P < 0.001 vs. baseline and corresponding sham group.
CLI = sepsis; ES = endotoxemic shock; HS = hemorrhagic shock.
Fig. 2. Mean arterial pressure was significantly lower in the 
hemorrhagic shock (HS) than in any of the other groups. In 
endotoxemic shock (ES) and sepsis (CLI) groups, mean arte-
rial pressure decreased over time throughout the experiment 
compared with sham control. Statistical analysis for sham, 
CLI, and ES was performed from 0 to 6 h: *P < 0.05 for sham 
versus CLI. **P < 0.05 for sham versus ES. #P < 0.05 for CLI 
versus corresponding baseline. ##P < 0.05 for ES versus 
corresponding baseline. Statistical analysis for HS was per-
formed at 2 h: &P < 0.05 for HS versus all other groups. Data 
are given as means ± SEMs (n = 10 per group at the beginning 
of the experiment).
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Fig. 3. Ion-mobility spectrometry chromatogram of 3-pentanone. (A) Shows a typical ion-mobility spectrometer chromatogram 
for, respectively, individual rats in the sham, sepsis (CLI), endotoxemic shock (ES), and hemorrhagic shock (HS) groups after 4 h. 
(B) A three-dimensional plot of the same rats. Signals above a threshold of 1 mV defined a peak. The peaks were characterized 
by their position in the ion-mobility spectrometry chromatogram, using the inverse reduced mobility (axis of abscissa; 1/K0-
value—which is proportional to the drift time of the ions) and the retention time (axis of ordinates) as well as the peak expansion. 
Subsequently, peaks were identified according to database BS-multicapillary column/ion-mobility spectrometry-analytes (Ver-
sion 1209; B&S Analytik, Dortmund, Germany). For visualization, 3-pentanone is labeled as representative peak in this setting. 
Comparing the 3-pentanone peak, the drift time of 0.551 Vs/cm2, and a retention time of 8.2 s are equal in all chromatograms. 
The peak intensity after 4 h was 685 mV for sham, 370 mV for CLI, 60 mV for ES, and 585 mV for HS for this peak and is given 
as difference in color in A and size in B.
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A detailed peak examination revealed an early and strongly 
reduced release of ketones, acetone, and 3-pentanone during 
sepsis and inflammation. Our findings are consistent with previ-
ous reports showing that blood ketone bodies and the ketogenic 
capacity of the liver are inhibited during sepsis in rats.31,32 These 
findings seem to be independent of nutritional conditions because 
fasting before and during sepsis did not result in hypoglycemia.32 
Instead, increased tumor necrosis factor-α and interleukin-6 
plasma concentrations may mediate ketogenic impairment.33
Volatile acetone decreased over time in sepsis, inflamma-
tion, and HS, suggesting a hemodynamic dependence. But 
interestingly, other studies reported an increased acetone 
in exhaled breath of patients with heart failure, associated 
with an increase in blood brain natriatic peptide concentra-
tion.34,35 It thus seems unlikely that reduced acetone concen-
trations result from cardiac decompensation.
Guamán et al.15 selected acetone and a further 14 volatile 
compounds as possible compounds that can be potentially used 
to separate healthy rats from endotoxemic rats 24 h after lipo-
polysaccharide treatment using solid phase microextraction gas 
chromatography–mass spectrometry Schubert et al.35 reported 
that n-pentane concentrations are higher and that acetone 
Table 3. Identification and Changes in MCC-IMS Peaks
0 h 2 h 4 h 6 h 8 h 10 h
Survival rate (N =)
  Sham 10 10 10 10 10 10
  CLI 10 10 10 10 3 2
  ES 10 10 10 10 7 5
  HS 10 6 2
1-Propanol (CAS 71-23-8)
  Sham 29.3 (13.4–60.9) 31.9 (9.8–72.1) 30.6 (8.5–71.7) 28.3 (7.4–61.2) 26.7 (7.3–55.2) 26.2 (7.2–46.5)
  CLI 31.2 (16.0–70.2) 30.1 (10.9–62.8) 22.7 (7.3–42.9) 14.6† (6.9–22.1) 16.7 (10.4–29.1) 12.7 (9.3–16.0)
  ES 24.0 (6.3–51.3) 15.8* (5.4–38.8) 10.9* (4.3–21.7) 10.6* (6.1–18.1) 12.5 (9.8–17.9) 14.3 (10.5–23.3)
  HS 31.8 (24.4–47.0) 32.1 (26.4–51.5) 35.7 (26.9–47.2)
Butanal (CAS 123-72-8)
  Sham 11.8 (6.1–15.8) 13.4 (6.3–18.1) 13.6 (5.9–19.8) 12.7 (4.7–19.0) 12.8 (4.5–20.6) 13.2 (4.7–20.8)
  CLI 12.1 (8.1–15.3) 12.8‡ (6.9–16.9) 11.8‡ (9.7–13.5) 10.0‡ (6.0–12.4) 10.1 (8.3–12.1) 9.7 (8.8–10.6)
  ES 8.3 (5.8–15.4) 6.9* (4.5–12.0) 6.2* (4.2–9.6) 6.3* (4.6–9.3) 5.8 (4.7–8.9) 5.2 (4.0–6.9)
  HS 11.3 (7.0–18.3) 13.9‡ (6.5–24.1) 21.3 (8.4–30.7)
Acetophenone (CAS 98-86-2)
  Sham 3.8 (1.7–6.1) 4.5 (1.6–8.3) 5.1 (1.7–13.0) 4.6 (1.9–10.5) 5.1 (1.6–14.1) 5.0 (1.7–11.0)
  CLI 4.0 (1.8–6.1) 3.6 (1.7–5.2) 2.8 (1.0–4.1) 2.6 (1.7–4.6) 3.3 (2.1–4.4) 3.4 (3.0–3.9)
  ES 2.7 (1.6–7.1) 2.0* (1.1–2.9) 1.9* (1.5–2.4) 1.9* (1.1–2.7) 2.1 (1.5–2.6) 2.0 (1.7–2.2)
  HS 3.4 (2.2–6.6) 3.1 (1.9–6.5) 2.8 (2.8–2.8)
1,2-Butandiol (CAS 584-03-2)
  Sham 4.3 (1.5–9.0) 4.7 (2.1–8.8) 4.7 (1.8–9.3) 4.4 (1.8–7.5) 4.7 (2.2–10.3) 4.8 (2.0–8.2)
  CLI 4.1 (2.5–5.8) 4.0 (1.9–6.1) 3.6 (1.8–5.5) 3.5 (1.9–5.0) 3.0 (2.0–4.3) 2.3 (2.0–2.5)
  ES 2.9 (1.6–5.1) 2.4* (1.3–3.6) 2.3* (1.7–2.8) 2.5* (1.6–3.1) 2.4 (1.2–3.0) 2.6 (1.8–3.0)
  HS 2.8 (1.9–4.4) 2.7 (1.8–4.4) 2.3 (1.9–2.6)
3-Pentanone (CAS 96-22-0) shown in figure 4
Sham 481 (309–658) 541 (215–753) 528 (173–785) 499 (107–767) 485 (157–779) 482 (141–769)
CLI 495 (319–736) 489‡ (232–655) 353‡ (94.2–553) 213*† (80.8–293) 189 (129–224) 179 (113–244)
ES 404 (238–929) 153*† (131–432) 77.8*† (28.3–304) 75.8*† (33.3–240) 69 (32–181) 67 (43–135)
HS 553 (204–700) 654‡ (371–697) 576 (558–585)
Acetone (CAS 67-64-1) shown in figure 5
  Sham 118 (54.2–210) 163 (31.4–303) 172 (27.8–361) 154 (25.9–325) 155 (21.9–338) 153 (19.8–320)
  CLI 126 (53.6–286) 125 (44.9–218) 79.4* (22.8–143) 46.3*† (22.5–64.3) 44 (36.2–49.5) 43 (33.7–52.2)
  ES 106 (31.2–209) 58.8* (21.0–149) 33.5* (21.1–62.2) 28.6*† (21.7–48.7) 29 (22.2–38.8) 38 (24.4–79.5)
  HS 167 (23.9–358) 217‡ (130–319) 158 (140–167)
2-Hexanone (CAS 591-78-6) shown in figure 6
  Sham 21.3 (13.3–29.7) 22.2 (10.4–30.9) 20.7 (9.0–29.1) 19.5 (9.3–28.8) 19.3 (8.6–30.7) 19.0 (7.2–29.7)
  CLI 22.9 (18.6–31.3) 20.8‡ (14.4–26.9) 18.2‡ (9.6–22.7) 16.0† (8.0–20.0) 19.7 (13.0–25.9) 18.0 (13.2–22.7)
  ES 18.3 (10.5–33.7) 12.6* (7.1–18.2) 10.5* (6.0–15.0) 11.3*† (7.9–14.5) 12.1 (9.5–14.6) 13.7 (9.9–20.6)
  HS‡ 21.0 (17.7–27.0) 27.6§ (21.0–33.1) 33.8 (29.0–43.2)
Data are given as means ± 95% CI. Seven volatile organic compounds with significant changes for peak intensities among the groups were found during 
the experiment (presented in table 3). Three of them were illustrated in figures 4–6. Statistical analysis was performed from 0 to 6 h.
* P < 0.05 vs. sham group. † P < 0.05 vs. corresponding baseline. ‡ P < 0.05 vs. LPS. § P < 0.05 vs. all other groups.
CAS = chemical abstract service registry number; CLI = sepsis; ES = endotoxemic shock; HS = hemorrhagic shock; MCC-IMS = multicapillary column 
ion-mobility spectrometry.
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concentrations are lower in the blood of mechanically venti-
lated septic patients than in healthy controls. However, GC/
MS revealed no differences in the concentration of either sub-
stance in the breath of the patient groups. In contrast, previous 
studies showed increased concentrations of acetone, dimethyl 
sulfide, 2-butanone, and 2-pentanone in the breath of patients 
with liver cirrhosis and in the headspace samples of different 
bacteria.8,29,36 The extent to which any of these VOCs might 
serve as useful diagnostic criteria for sepsis thus remains unclear.
Our study is limited in so far as rodent models only par-
tially correlate with human conditions.37 However, the sepsis 
Fig. 4. Peak course of 3-pentanone. For 3-pentanone, 
sham and hemorrhagic shock (HS) rats exhibited stable sig-
nal strength during the experiment. In endotoxemic shock 
(ES) and sepsis (CLI), 3-pentanone concentrations declined 
during the observation period. Statistical analysis was 
performed from 0 to 6 h: *P < 0.05 for sham versus CLI. 
**P < 0.05 for sham versus ES. §P < 0.05 for CLI versus 
ES. #P < 0.05 for CLI versus corresponding baseline. 
##P < 0.05 for ES versus corresponding baseline. Data are 
given as means ± SEMs.
Fig. 5. Peak course of acetone. Examples of an acetone peak 
declining during hemorrhagic shock (HS), endotoxemic shock 
(ES), and sepsis (CLI). Statistical analysis was performed from 
0 to 6 h: *P < 0.05 for sham versus CLI. **P < 0.05 for sham 
versus ES. #P < 0.05 for CLI versus corresponding baseline. 
##P < 0.05 for ES versus corresponding baseline. Data are 
given as means ± SEMs.
Fig. 6. Peak course of 2-hexanone. 2-Hexanone increased 
significantly more after induction of hemorrhagic shock (HS) 
than other treatments. 2-Hexanone decreased in endotox-
emic shock (ES) compared with sham control and sepsis 
(CLI). Statistical analysis was performed from 0 to 6 h: **P < 
0.05 for sham versus ES. §P < 0.05 for CLI versus ES. #P < 
0.05 for CLI versus corresponding baseline. ##P < 0.05 for 
ES versus corresponding baseline. Statistical analysis for 
HS was performed at 2 h: &P < 0.05 for HS versus all other 
groups. Data are given as means ± SEMs.
Table 4. Overview of Changes in Volatile Compound Profiles
1-Propanol 3-Pentanone Acetone 2-Hexanone
2 h 6 h 2 h 6 h 2 h 6 h 2 h 6 h
Sham → → → →
CLI ↓ ↓ ↓ ↓
ES → ↓ ↓ ↓
HS → → → ↑
Four volatile organic compounds displayed significant differences for CLI 
or ES after 6 h, when compared with corresponding baseline values. Two 
hours after HS, 2-hexanone was associated with a significant increase in 
intensity compared with baseline. Significant changes in volatile compound 
profiles are given as directional arrows: → stable, ↓ decline, ↑ increase.
CLI = sepsis; ES = endotoxemic shock; HS = hemorrhagic shock.
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and the inflammation model we chose are standard ones that 
have been used in many previous studies. A more important 
limitation is that we do not know whether expired breath 
markers of inflammation and sepsis can detect the conditions 
in humans before they are otherwise clinically apparent.
In summary, MCC-IMS analysis of expired gas may help 
identify sepsis or inflammation. Future studies should evalu-
ate plausible mechanisms for changes in VOC quantities and 
which breath profiles best indicate a septic or inflammatory 
state. Thereafter, breath analysis for sepsis and inflammation 
needs to be confirmed in humans, and its sensitivity and 
specificity determined.
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